Evidence map›Paper›PMID 34183956›Full record

ArticleIranian journal of public health2021

Relationship between

Milad Heidari Nia, Mahdieh Jafari Shahroudi, Ramin Saravani, Saman Sargazi, Mahdiyeh Moudi, Azizollah Mojahed

Abstract read
In one paragraph

Article in Iranian journal of public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Milad Heidari NiaCellular and Molecular Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.
Mahdieh Jafari ShahroudiCellular and Molecular Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.
Ramin SaravaniCellular and Molecular Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.
Saman SargaziCellular and Molecular Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.
Mahdiyeh MoudiCellular and Molecular Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.
Azizollah MojahedHealth Promotion Research Center, Department of Clinical Psychology, Zahedan University of Medical Sciences, Zahedan, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSchizophrenia (SZN) is a heterogeneous disorder. Recently, the role of purinergic receptor's signaling in mental disorders has implicated. There is no evidence regarding the association of

methodsThis case-control study was performed on 150 SZN patient referring to Baharan Hospital, Zahedan (Eastern of Iran) in 2018. Genotyping was done by tetra-amplification refractory mutation system polymerase chain reaction (Tetra ARMS-PCR). Different databases were used to determine the effects of the SNPs on the secondary structure of

resultsThe G allele of rs1169727 significantly increased the risk of SZN (OR=1.41, 95%CI=1.02-1.93,

conclusionrs1169727A/G and rs25644A/G are linked to SZN susceptibility in a sample of the Iranian population. In-silico analysis indicated that rs25644 have substantial roles in determining the pre-mRNA and protein structure of

Indexed as

In-silicoPurinergic receptorsSchizophrenia

Identifiers

PMID34183956
PMCPMC8223582

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.